Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Ethics Statement
Ask a
question
Favorite
This prospective, randomized clinical trial was approved by the Clinical Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University, Hefei, China (approval number: PJ2020-01-07) and was registered at Chinese Clinical trial Registry (http://www.chictr.org.cn/index.aspx, registration number: ChiCTR2000029932). This study was conducted in accordance with the declaration of Helsinki.
Copyright and License information: ©2021 Liu et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
